[ad_1]
Bandung –
In a viral snippet, the World Health Organization (WHO) chief scientist Soumya Swaminathan is said to have said that clinical trials of several Corona COVID-19 vaccines manufactured in China were successful. It was later revealed that the quote was incomplete.
One of the vaccines developed by China, namely Sinovac, is currently in clinical trials in Bandung, West Java. Eddy Fadlyana, Field Director of the COVID-19 Vaccine Clinical Trial Research Team at Padjadjaran University School of Medicine, said the Sinovac vaccine trial in Bandung would still be carried out in accordance with the existing regulations.
“The third phase is still ongoing. So in all of Brazil, the initial reports have not been completed. Only in a pandemic, the WHO can decide whether to get vaccinated or not,” Eddy said when contacted by detik.com on Friday. (9/25/2020).
In addition, he emphasized that the vaccine efficacy test was carried out for 6 months after the first immunization was carried out, then it could be classified as successful or not. Meanwhile, the implementation of trials in Indonesia with other countries was almost simultaneously only two weeks apart.
“So even January in Bandung has finished the initial stage. If it can be used, the POM Agency will make a mass policy, so that it can be used in January. If the policy is with the POM,” he said.
He explained that the test implementation was divided into two parts. First, by January 2021, 540 people completed the test. You can learn about blood tests, antibody levels, and vaccine safety.
Watch video “Sick volunteers, final testing of UK vaccine candidates postponed“
[Gambas:Video 20detik]
